RiverVest Venture Partners

RiverVest Venture Partners

Recent News about RiverVest Venture Partners

Edit
More about RiverVest Venture Partners
Edit

RiverVest Venture Partners - Investing in Life Science Innovation Investing in Life Science Innovation Home About Us Team Portfolio Case Studies News All News RiverVest News Newsletters Contact Us Growing Companies RiverVest identifies and shapes companies, creating significant shareholder value. About Us Proven Experience More than 15 years experience in research, clinical, operational and investment success give the RiverVest team an edge in producing top-tier results. Meet The Team Case Studies RiverVest has successfully funded 34 life sciences companies and facilitated 20 public offerings or exits. View Case Studies RiverVest Venture Partners® is a venture capital firm focused on identifying and shaping early-stage life science companies to create significant shareholder value. Because of its extensive operating expertise, RiverVest is able to help entrepreneurs achieve near-term objectives that position their companies for exit. Portfolio Companies Portfolio Company News Securus Medical Group, Inc. Announces Series C Financing and 510(k) Clearance September 15, 2016 Amplyx Pharmaceuticals Initiates Dosing in Phase 1 Clinical Trial of APX 001, a Novel Antifungal Product Candidate for Treatment of Life-Threatening Infections September 12, 2016 Allakos Initiates Phase 2 Trial of AK001 in Patients with Nasal Polyposis September 8, 2016 Tioma Therapeutics Announced $86 Million Series A Financing August 16, 2016 Otonomy Successfully Completes One-Year, Multiple-Dose Clinical Safety Trial for OTO-104 in Ménières Disease Patients August 1, 2016 More News Recent Tweets RiverVest co-leads $86 million Series A financing for St. Louis-founded startup Tioma t.co/iEKDTHeRJ3 Time ago 1 Day via Hootsuite Reply - Retweet - Favorite RT @mindsofmalady: #pharma #startup Amplyx develop treatments for life-threatening fungal infections t.co/1K0Lj5ujth #cancer https: Time ago 2 Days via Twitter for iPhone Reply - Retweet - Favorite RiverVest portfolio company Securus closes on $10 million Series C financing led by Boston Scientific t.co/Tj1OKpTPrH Time ago 2 Days via Hootsuite Reply - Retweet - Favorite Follow @Rivervest on twitter. RiverVest News RiverVest Venture Partners co-leads $86 million Series A financing for St. Louis-founded startup Tioma September 16, 2016 RiverVest Opens San Diego Office Thats Been 10 Years in the Making April 13, 2016 Nancy A. Hong Joins RiverVest Venture Partners as Life Sciences VC Opens Office in San Diego April 7, 2016 RiverVest Venture Partners Closes on $80 Million Life Sciences Fund May 5, 2015 Big year: RiverVest turns in strong 2014, eyes 2015 growth January 28, 2015 More RiverVest News Newsletter Sign Up Copyright © 2016 RiverVest · All Rights Reserved · Powered by NeuConcept